Sleep disturbances and pain among individuals with prescription opioid dependence
- PMID: 24999989
- PMCID: PMC4324972
- DOI: 10.1016/j.addbeh.2014.05.025
Sleep disturbances and pain among individuals with prescription opioid dependence
Abstract
Background: Poor sleep quality has been observed in individuals with substance use disorders and is often a trigger for relapse. To date, little research has investigated sleep quality among individuals with prescription opioid (PO) dependence. The present study aimed to address this gap in the literature by examining subjective and objective sleep disturbances among PO dependent individuals.
Methods: Subjects were 68 non-treatment seeking individuals (33 PO dependent, 35 healthy controls). Subjective sleep was assessed with the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI). Subjects were admitted for an overnight inpatient hospital stay during which objective sleep data was collected using an actigraphy device. Self-report pain was measured with the Brief Pain Inventory.
Results: Significant group differences in subjective sleep quality were revealed in the PSQI (p<0.01) and ISI (p<0.01). Poor sleep quality (i.e., PSQI total score>5) was identified in 80.6% of the PO group, as compared to 8.8% of the control group (p<.001). Significant group differences in sleep quality were identified in five of six actigraphy variables: total time asleep, sleep efficiency, latency of onset of sleep, total time awake and time mobile. Furthermore, significant associations between pain severity and sleep quality were observed.
Conclusions: Results indicate high rates of sleep impairment and poor sleep quality among PO dependent individuals. Pain severity was significantly correlated with sleep quality. Although preliminary, the findings highlight the importance of assessing and treating sleep disturbances, as well as pain, among patients with PO dependence.
Keywords: Actigraphy; Opiates; Prescription opioids; Sleep; Sleep disturbance.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.Inflamm Bowel Dis. 2019 May 4;25(6):1044-1053. doi: 10.1093/ibd/izy324. Inflamm Bowel Dis. 2019. PMID: 30395256
-
Sleep disturbance in patients taking opioid medication for chronic back pain.Anaesthesia. 2016 Nov;71(11):1296-1307. doi: 10.1111/anae.13601. Epub 2016 Aug 22. Anaesthesia. 2016. PMID: 27545291 Free PMC article.
-
Subjective and objective sleep quality modulate emotion regulatory brain function in anxiety and depression.Depress Anxiety. 2017 Jul;34(7):651-660. doi: 10.1002/da.22622. Epub 2017 Apr 18. Depress Anxiety. 2017. PMID: 28419607 Free PMC article.
-
Rheumatoid arthritis is associated with negatively variable impacts on domains of sleep disturbances: evidence from a systematic review and meta-analysis.Psychol Health Med. 2021 Mar;26(3):267-277. doi: 10.1080/13548506.2020.1764597. Epub 2020 May 18. Psychol Health Med. 2021. PMID: 32420757
-
Sleep Disturbances in Pediatric Chronic Fatigue Syndrome: A Review of Current Research.J Clin Sleep Med. 2015 Jul 15;11(7):757-64. doi: 10.5664/jcsm.4854. J Clin Sleep Med. 2015. PMID: 25766714 Free PMC article. Review.
Cited by
-
Sex-specific role of the circadian transcription factor NPAS2 in opioid tolerance, withdrawal and analgesia.Genes Brain Behav. 2022 Sep;21(7):e12829. doi: 10.1111/gbb.12829. Epub 2022 Aug 20. Genes Brain Behav. 2022. PMID: 36053258 Free PMC article.
-
Metabotropic glutamate receptor function and regulation of sleep-wake cycles.Int Rev Neurobiol. 2023;168:93-175. doi: 10.1016/bs.irn.2022.11.002. Epub 2023 Jan 13. Int Rev Neurobiol. 2023. PMID: 36868636 Free PMC article.
-
A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice.Psychopharmacology (Berl). 2022 Oct;239(10):3185-3200. doi: 10.1007/s00213-022-06200-x. Epub 2022 Aug 1. Psychopharmacology (Berl). 2022. PMID: 35915264 Free PMC article.
-
Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado.Subst Abuse Treat Prev Policy. 2022 Jan 3;17(1):1. doi: 10.1186/s13011-021-00424-4. Subst Abuse Treat Prev Policy. 2022. PMID: 34980179 Free PMC article.
-
Noribogaine acute administration in rats promotes wakefulness and suppresses REM sleep.Psychopharmacology (Berl). 2024 Jul;241(7):1417-1426. doi: 10.1007/s00213-024-06572-2. Epub 2024 Mar 12. Psychopharmacology (Berl). 2024. PMID: 38467891
References
-
- Aghajanian GK. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978;276(5684):186–188. - PubMed
-
- Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342–392. - PubMed
-
- Assad TA, Ghanem MH, Abdel Samee AM, El-Habiby MM. Sleep profile in patients with chronic opioid abuse: A polysomnographic evaluation in an Egyptian sample. Addict Disord Their Treat. 2011;10:21–28.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous